Single-institution Study Evaluating the Utility of Surveillance Bronchoscopy After Lung Transplantation

Journal of Heart and Lung Transplantation

Volumn 28, Issue 1, 2009, Pages 14-20

  Valentine, Vincent G ^a   Gupta, Meera R ^a   Weill, David ^b   Lombard, Gisele A ^a   LaPlace, Stephanie G ^c   Seoane, Leonardo ^c   Taylor, David E ^c   Dhillon, Gundeep S ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c OCHSNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HEALTH SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MEDICAL SOCIETY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; FEMALE; GRAFT REJECTION; HUMANS; INFECTION; LENGTH OF STAY; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MULTICENTER STUDIES AS TOPIC; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 58149144580     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.10.010     Document Type: Article

References (39)

1. Bando K., Paradis I.L., Similo S., et al. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 110 (1995) 4-13
2. Boehler A., and Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 22 (2003) 1007-1018
3. Girgis R.E., Tu I., Berry G.J., et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 15 (1996) 1200-1208
4. Heng D., Sharples L.D., McNeil K., et al. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 17 (1998) 1255-1263
5. Husain A.N., Siddiqui M.T., Holmes E.W., et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 159 (1999) 829-833
6. Knoop C., and Estenne M. Acute and chronic rejection after lung transplantation. Semin Respir Crit Care Med 27 (2006) 521-533
7. Scott J.P., Higenbottam T.W., Sharples L., et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 51 (1991) 813-817
8. Hopkins P.M., Aboyoun C.L., Chhajed P.N., et al. Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med 170 (2004) 1022-1026
9. Khalifah A.P., Hachem R.R., Chakinala M.M., et al. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant 5 (2005) 2022-2030
10. Patel S.R., Kirby T.J., McCarthy P.M., et al. Lung transplantation: the Cleveland Clinic experience. Cleve Clin J Med 60 (1993) 303-319
11. Tamm M., Sharples L.D., Higenbottam T.W., et al. Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies. Am J Respir Crit Care Med 155 (1997) 1705-1710
12. Valentine V.G., Taylor D.E., Dhillon G.S., et al. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant 21 (2002) 319-326
13. Kukafka D.S., O'Brien G.M., Furukawa S., and Criner G.J. Surveillance bronchoscopy in lung transplant recipients. Chest 111 (1997) 377-381
14. Orens J.B., Estenne M., Arcasoy S., et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 25 (2006) 745-755
15. Frost A.E. Donor criteria and evaluation. Clin Chest Med 18 (1997) 231-237
16. Valentine V., McFadden P.M., and Ochsner J.L. Advances in lung transplantation. Ochsner J 1 (1999) 12-18
17. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 152 (1995) 1107-1136
18. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection. J Heart Lung Transplant 15 (1996) 1-15
19. Cooper J.D., Billingham M., Egan T., et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 12 (1993) 713-716
20. Valentine V.G., Bonvillain R.W., Gupta M.R., et al. Infections in lung allograft recipients: ganciclovir era. J Heart Lung Transplant 27 (2008) 528-535
21. Dransfield M.T., Garver R.I., and Weill D. Standardized guidelines for surveillance bronchoscopy reduce complications in lung transplant recipients. J Heart Lung Transplant 23 (2004) 110-114
22. Paradis I.L., Duncan S.R., Dauber J.H., et al. Distinguishing between infection, rejection, and the adult respiratory distress syndrome after human lung transplantation. J Heart Lung Transplant 11 suppl (1992) S232-S236
23. Sibley R.K., Berry G.J., Tazelaar H.D., et al. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant 12 (1993) 308-324
24. Starnes V.A., Theodore J., Oyer P.E., et al. Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg 98 (1989) 683-690
25. Trulock E.P., Ettinger N.A., Brunt E.M., et al. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest 102 (1992) 1049-1054
26. Boehler A., and Estenne M. Obliterative bronchiolitis after lung transplantation. Curr Opin Pulmon Med 6 (2000) 133-139
27. Chakinala M.M., Ritter J., Gage B.F., et al. Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation. J Heart Lung Transplant 23 (2004) 1396-1404
28. Baz M.A., Ghio A.J., Roggli V.L., et al. Iron accumulation in lung allografts after transplantation. Chest 112 (1997) 435-439
29. Vitulo P., Cremaschi P., Arbustini E., et al. Surveillance transbronchial biopsy in the diagnosis of acute lung rejection in heart and lung and lung transplant recipients. Monaldi Arch Chest Dis 51 (1996) 12-15
30. Studer S.M., Orens J.B., Rosas I., et al. Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection. J Heart Lung Transplant 20 (2001) 1158-1166
31. Van Muylem A., Knoop C., and Estenne M. Early detection of chronic pulmonary allograft dysfunction by exhaled biomarkers. Am J Respir Crit Care Med 175 (2007) 731-736
32. Kuo E., Bharat A., Goers T., et al. Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation. Ann Thorac Surg 82 (2006) 1043-1050
33. Kurian S., Grigoryev Y., Head S., et al. Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers. Int Immunopharmacol 7 (2007) 1948-1960
34. Mansfield E.S., and Sarwal M.M. Arraying the orchestration of allograft pathology. Am J Transplant 4 (2004) 853-862
35. Trulock E.P., Edwards L.B., Taylor D.O., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 25 (2006) 880-892
36. Weill D., Lock B.J., Wewers D.L., et al. Combination prophylaxis with ganciclovir and cytomegalovirus (CMV) immune globulin after lung transplantation: effective CMV prevention following daclizumab induction. Am J Transplant 3 (2003) 492-496
37. Luckraz H., Sharples L., McNeil K., et al. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation. J Heart Lung Transplant 22 (2003) 287-291
38. Tamm M., Aboyoun C.L., Chhajed P.N., et al. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 170 (2004) 1120-1123
39. Mullen J.C., Oreopoulos A., Lien D.C., et al. A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation. J Heart Lung Transplant 26 (2007) 504-510